Hemodynamic state was primarily assessed by mixed venous oxygen saturation (SvO 2 ).Follow-up averaged 9.7±1.4 years.Results LVEF was 0.30 ± 0.05 (range 0.20-0.37) and 3.5 ± 1.3 vessels were bypassed.Inotropes were used in 6.7% for weaning from CPB. Increase of s-creatinine by 50% compared to preoperative values was observed in 2.9 %. Logistic EuroSCORE was 8.3%whereas observed 30-day mortality was 1.0%. Crude 5-year survival was 89.4%.
ConclusionsThe metabolic strategy allowed restrictive use of inotropes and was associated with encouraging long-term survival. Renal function was well preserved suggesting that SvO 2 served as an adequate marker of circulation. Randomized trials with metabolic support are warranted.